India, EU to resolve generic drugs expots tangleNovember 6th, 2009 NEW DELHI - The European Union (EU) is not opposed to exports of generic medicine by Indian companies through its ports, European Commissioner for Trade Catherine Ashton said here Friday. Answering a query on the confiscation of Indian consignments of generic medicine in European ports, which were bound for other countries, she said EU would soon resolve the issue.
AstraZeneca posts 22 percent rise in third quarter profits amid demand for swine flu vaccineOctober 29th, 2009 more images
more images
AstraZeneca 3Q earns up 22 percent
LONDON — Pharmaceutical company AstraZeneca PLC posted a 22 percent rise in third quarter net profit on Thursday, boosted by initial sales of its swine flu vaccine and delayed entry of generic drug competition in the United States. The expectation of further profits expected from its Novel Influenza A vaccine for the H1N1 led AstraZeneca to lift its full-year earnings forecast.
Hospira profit climbs on sales of generic chemotherapy treatment and other specialty drugsOctober 27th, 2009 more images
more imagesChemotherapy drug sales boost Hospira 3Q profitLAKE FOREST, Ill. — Hospira Inc.
Shire says FDA reaffirms 5-year market exclusivity period for ADHD drug VyvanseOctober 26th, 2009 Shire says FDA reaffirms Vyvanse exclusivityNEW YORK — Shire PLC said the U.S. Food and Drug Administration reaffirmed a prior decision to give the attention-deficit-hyperactivity disorder drug Vyvanse five-years of market exclusivity.
MBBS students should have separate paper on mental health: NHRCOctober 19th, 2009 NEW DELHI - Mental illness will be the biggest health risk in India by next year but the number of specialist doctors to deal with it is grossly inadequate. Hoping to fill the huge gap, the National Human Rights Commission (NHRC) has suggested that mental health be made a separate subject for medical students.
Madhya Pradesh forms team to probe spread of dengueOctober 9th, 2009 BHOPAL - Alarmed over the spread of mosquito-borne dengue fever in the state, the Madhya Pradesh government has set up a committee to investigate why the disease was spreading so fast, Health Minister Anoop Mishra said Friday. "An investigating committee has been constituted which will work under the supervision of Dr.
Check sweet intake, stay healthySeptember 26th, 2009 NEW DELHI - With five percent of India's population obese, there is a strong need to control intake of sweets and maintain an active lifestyle so as to stay fit. "Indians by nature have a sweet tooth and sugar is a prime requirement in every household.
Pharma exports up 29 percent to $9.35 bnSeptember 25th, 2009 HYDERABAD - India's exports of drugs, pharmaceuticals and fine chemicals grew by 29 percent last fiscal to Rs.39,538 crore (around $9.35 billion) compared to the previous fiscal, Commerce and Industry Minister Anand Sharma said Friday. "In recent times, the Indian pharmaceutical sector has emerged as one of the major contributors to Indian exports with export earnings rising from a negligible amount in early 1990s to Rs.29,139.57 crore by 2007-08," Sharma said while addressing the Indo-Africa Pharma Business Meet here.
Decks cleared for Orchid to market anti-infectives in USSeptember 25th, 2009 CHENNAI - Decks have been cleared for the city-based Orchid Chemicals and Pharmaceuticals for marketing the generic versions of Zosyn antibiotic, with a US district court rejecting rival Wyeth Laboratories' motion for a restraint on the sale of the drug. Wyeth had filed a suit in the District Court of Columbia against the US Food and Drug Administration's (FDA) decision to grant Orchid permission to sell generic Zosyn, chemically Piperacillin-Tazobactam, claiming the drug could harm critically ill patients.
Indian pharma exports up by 29 percent in 2008-09September 25th, 2009 HYDERABAD - Union Minister of Commerce and Industry Anand Sharma today said that the exports of drugs, pharmaceuticals and fine chemicals for the year 2008-09 stood at Rs.39,538 crore, registering a growth of about 29 per cent over the last year. Addressing the Indo-Africa Pharma Business meet here, Sharma said: "In recent times, the Indian pharmaceutical sector has emerged as one of the major contributors to Indian exports with export earnings rising from a negligible amount in early 1990s to Rs.29,139.57 crore by 2007-08.
1.25 mn capsules of new swine flu drug enter Indian marketSeptember 25th, 2009 NEW DELHI - As swine flu cases continue to surge in the country, a pharma company Friday announced that it has pushed 1.25 million capsules of the drug to chemists across the country to combat the virus and it would be ready with 10 million such drugs by mid-October. We have launched Natflu capsules (generic version of Tamiflu - Oseltamivir), the first cure for swine flu to be available against medical prescription at designated chemists across India, said V.C.
Lucknow's medical institute gets new chiefSeptember 20th, 2009 LUCKNOW - R.K. Sharma was Sunday appointed director of the Sanjay Gandhi Post-Graduate Institute of Medical Sciences (SGPGIMS) here, replacing controversial incumbent A.K.
Indian pharma to be involved in $150 mn global vaccine ventureSeptember 18th, 2009 LONDON - Indian generic drug companies will be the first to be called to collaborate with a $150 million joint venture between the US pharmaceutical giant Merck and British medical charity Wellcome Trust to develop and produce new vaccines in India. The new company, MSD Wellcome Trust Hilleman Laboratories, will have 60 staff who will develop cheap vaccines for neglected diseases that are common in developing countries, CEO Altaf A.
Swine flu scare to hit foreign tourist inflow to RajasthanSeptember 10th, 2009 JAIPUR - Foreign tourist arrivals in Rajasthan may drop by as much as 30 percent due to the swine flu scare, industry players say. The tourism season in Rajasthan is mainly from October to March, and if enquiries the travel agents are receiving are an indication, the state is faced with a plunge in arrivals this year.
India says no to AIDS drug patents, reaffirms role as 'pharmacy' of poor countriesSeptember 4th, 2009 LONDON - India has rejected applications from two US companies for patents on two key AIDS drugs in a move that could mean more people in poor countries will have access to life-saving medicines. According to a report in Nature News, the decisions are the latest in a string of legal victories for Cipla, India's largest generic drug maker.
NEW DELHI - Trade Minister Anand Sharma has said that India will resolve a dispute with the European Union over generic drugs in an amicable way.
